Study of Safety and Efficacy of Tropifexor (LJN452) in Patients With Non-alcoholic Steatohepatitis (NASH)
Clinical trial NCT02855164 · TERMINATED
Trial details
- NCT number
- NCT02855164
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-01
- Primary completion
- 2020-04-06
- Enrollment
- 350
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.